My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Poly Medicure surges after good Q3 result, liberal bonus issue
Feb 07,2017

The announcement was made after market hours on Monday, 6 February 2017.

Meanwhile, the S&P BSE Sensex was down 34.59 points, or 0.12% to 28,404.69

On the BSE, 5,408 shares were traded on the counter so far as against the average daily volumes of 1,720 shares in the past one quarter. The stock had hit a high of Rs 515 and a low of Rs 498 so far during the day. The stock hit a 52-week high of Rs 538 on 3 February 2017. The stock hit a 52-week low of Rs 238 on 12 February 2016.

The small-cap company has equity capital of Rs 22.06 crore. Face value per share is Rs 5.

Poly Medicures net profit jumped 42.69% to Rs 15.04 crore on 23.62% increase in net sales to Rs 111.99 crore in Q3 December 2016 over Q3 December 2015. The result was announced after market hours on Monday, 6 February 2017.

Poly Medicure operates within the surgical and medical instruments sector.

Powered by Capital Market - Live News

NBCC (India) moves higher after providing business update
Feb 07,2017

The announcement was made after market hours on Monday, 6 February 2017.

Meanwhile, the S&P BSE Sensex was down 2.99 points, or 0.01%, to 28,436.29

On the BSE, 21,000 shares were traded on the counter so far as against the average daily volumes of 2.23 lakh shares in the past one quarter. The stock had hit a high of Rs 282.25 and a low of Rs 279.60 so far during the day. The stock hit a record high of Rs 299.20 on 5 October 2016. The stock hit a 52-week low of Rs 162 on 12 February 2016.

The large-cap company has equity capital of Rs 120 crore. Face value per share is Rs 2.

Seperately, NBCC (India) also announced signing a tripartite memorandum of understanding (MoU) with Ministry of Tourism and State Government of Jammu and Kashmir.

Shares of NBCC (India) are currently trading 1:2 cum bonus for which record date has been fixed as 21 February 2017.

NBCC (India)s consolidated net profit rose 1.42% to Rs 69.11 crore on 15.75% increase in net sales to Rs 1224.41 crore in Q2 September 2016 over Q2 September 2015.

NBCC (India) is a blue-chip Government of India (GoI) Navratna Enterprise under the Ministry of Urban Development, in construction sector. The GoI held 75% stake in the firm (as per shareholding pattern as on 31 December 2016).

Powered by Capital Market - Live News

Concor gains as board to consider issue of bonus shares
Feb 06,2017

The announcement was made during market hours today, 6 February 2017.

Meanwhile, the S&P BSE Sensex was up 193.77 points or 0.69% at 28,434.29

On BSE, so far 1.41 lakh shares were traded in the counter as against average daily volume of 24,361 shares in the past one quarter. The stock hit a high of Rs 1,298.95 and a low of Rs 1,207.95 so far during the day. The stock had hit a 52-week high of Rs 1,544 on 2 August 2016. The stock had hit a 52-week low of Rs 1,050.85 on 12 February 2016.

The large-cap company has equity capital of Rs 194.97 crore. Face value per share is Rs 10.

Container Corporation of India (Concor)s net profit dropped 31.87% to Rs 157.84 crore on 8.2% decline in net sales to Rs 1378.61 crore in Q2 September 2016 over Q2 September 2015.

Concor provides logistics solutions. It has the largest network of inland container depots (ICDs)/container freight stations in India. In addition to providing inland transport by rail for containers, it has also expanded to cover management of ports, air cargo complexes and establishing cold-chain. The Government of India (GoI) holds 56.75% stake in Concor (as per the shareholding pattern as on 31 December 2016).

Powered by Capital Market - Live News

Abbott India jumps after decent Q3 results
Feb 06,2017

The result was announced during trading hours today, 6 February 2017.

Meanwhile, the BSE Sensex was up 227.54 points, or 0.81%, to 28,468.06.

On the BSE, so far 2,687 shares were traded in the counter, compared with average daily volumes of 430 shares in the past one quarter. The stock had hit a high of Rs 4,675.50 and a low of Rs 4,450 so far during the day.

The stock hit a 52-week high of Rs 5,220 on 4 March 2016. The stock hit a 52-week low of Rs 4,351 on 24 January 2017.

The mid-cap company has equity capital of Rs 21.25 crore. Face value per share is Rs 10.

Abbott India, a subsidiary of Abbott Laboratories, offers medicines in multiple therapeutic categories such as womens health, gastroenterology, cardiology, metabolic disorders and primary care. Abbott India is part of Abbotts global pharmaceutical business in India.

Powered by Capital Market - Live News

HDIL leads gainers in A group
Feb 06,2017

HDIL jumped 9.72% to Rs 71.70 at 14:47 IST. The stock topped the gainers in the BSEs A group. On the BSE, 58.39 lakh shares were traded on the counter so far as against the average daily volumes of 17.58 lakh shares in the past two weeks.

Shree Renuka Sugars surged 7.92% to Rs 16.35. The stock was the second biggest gainer in A group. On the BSE, 29.14 lakh shares were traded on the counter so far as against the average daily volumes of 5.93 lakh shares in the past two weeks.

Bajaj Finserv gained 6.9% at Rs 3,674.05. The stock was the third biggest gainer in A group. On the BSE, 40,000 shares were traded on the counter so far as against the average daily volumes of 15,000 shares in the past two weeks.

Just Dial advanced 5.39% at Rs 399.80. The stock was the fourth biggest gainer in A group. On the BSE, 5.11 lakh shares were traded on the counter so far as against the average daily volumes of 2.16 lakh shares in the past two weeks.

Jubilant FoodWorks rose 7.56% to Rs 988.35. The stock was the fifth biggest gainer in A group. On the BSE, 1.99 lakh shares were traded on the counter so far as against the average daily volumes of 80,000 shares in the past two weeks.

Powered by Capital Market - Live News

Enkei Wheels (India) drops after dismal Q3 result
Feb 06,2017

The result was announced after market hours on Friday, 3 February 2017.

Meanwhile, the BSE Sensex was up 225.17 points, or 0.8%, to 28,465.69

On BSE, so far 10,000 shares were traded in the counter, compared with an average volume of 2,758 shares in the past one quarter. The stock hit a high of Rs 181 and a low of Rs 172.10 so far during the day. The stock hit a 52-week high of Rs 221 on 24 October 2016. The stock hit a 52-week low of Rs 116 on 1 March 2016.

The small-cap auto component maker has an equity capital of Rs 7.44 crore. Face value per share is Rs 5.

Enkei Wheels (India) is a manufacturer of the aluminum alloy wheels to two wheelers as well as four wheelers.

Powered by Capital Market - Live News

Volumes jump at IIFL Holdings counter
Feb 06,2017

IIFL Holdings clocked volume of 1.59 crore shares by 13:27 IST on BSE, a 429.34-times surge over two-week average daily volume of 37,000 shares. The stock rose 2.36% to Rs 323.30.

Cyient notched up volume of 5.96 lakh shares, a 133.28-fold surge over two-week average daily volume of 4,000 shares. The stock rose 1.67% to Rs 464.

Time Technoplast saw volume of 12.20 lakh shares, a 54.02-fold surge over two-week average daily volume of 23,000 shares. The stock rose 6.27% to Rs 94.10.

Container Corporation of India clocked volume of 1.04 lakh shares, a 10.52-fold surge over two-week average daily volume of 10,000 shares. The stock rose 4.59% to Rs 1,269.10.

Laurus Labs saw volume of 3.41 lakh shares, a 9.27-fold rise over two-week average daily volume of 37,000 shares. The stock rose 10.06% to Rs 553.

Powered by Capital Market - Live News

Excel Inds tumbles as Q3 net profit boosted by other income
Feb 06,2017

The result was announced after market hours on Friday, 3 February 2017.

Meanwhile, the S&P BSE Sensex was up 224.57 points or 0.8% at 28,465.09

On BSE, so far 8,788 shares were traded in the counter as against average daily volume of 2,612 shares in the past one quarter. The stock hit a high of Rs 401 and a low of Rs 376.60 so far during the day. The stock had hit a 52-week high of Rs 496 on 1 November 2016. The stock had hit a 52-week low of Rs 140 on 12 February 2016.

The small-cap company has equity capital of Rs 6.45 crore. Face value per share is Rs 5.

Excel Industries net profit surged 904.74% to Rs 21.20 crore on 7.12% decline in net sales to Rs 94.51 crore in Q3 December 2016 over Q3 December 2015. The Q3 December 2016 net profit was boosted by an exceptional income of Rs 26.68 crore. During Q3 December 2016, Excel Industries sold 2.45 lakh shares of Excel Crop Care to Sumitomo Chemical Company, Japan at Rs 1259.36 per share. The profit earned (net of related expenses) has been disclosed as an exceptional item, Excel Industries.

Excel Industries is engaged in the manufacture of a range of speciality and performance chemicals.

Powered by Capital Market - Live News

Gokaldas Exports slumps after reverse turnaround in Q3
Feb 06,2017

The result was announced after market hours on Friday, 3 February 2017.

Meanwhile, the S&P BSE Sensex was up 215.65 points or 0.76% at 28,456.17

On BSE, so far 1.32 lakh shares were traded in the counter as against average daily volume of 60,261 shares in the past one quarter. The stock hit a high of Rs 63 and a low of Rs 59.70 so far during the day. The stock had hit a 52-week high of Rs 134.20 on 10 June 2016. The stock had hit a 52-week low of Rs 40.45 on 12 February 2016.

The small-cap company has equity capital of Rs 17.46 crore. Face value per share is Rs 5.

Gokaldas Exports net sales fell 21.92% to Rs 178.47 crore in Q3 December 2016 over Q3 December 2015.

Gokaldas Exports said that decline in revenue in Q3 December 2016 was due to continued impact of loss of business from a key export customer and delay in onboarding and stabilising operations of a new customer.

Gokaldas Exports manufactures and exports readymade garments.

Powered by Capital Market - Live News

Dr Reddys Lab drops after poor Q3 result
Feb 06,2017

The result was announced on Saturday, 4 February 2017.

Meanwhile, the S&P BSE Sensex was up 215.92 points or 0.76% at 28,456.44

On BSE, so far 33,000 shares were traded in the counter as against average daily volume of 25,920 shares in the past one quarter. The stock was volatile. The stock hit a high of Rs 3,175 and a low of Rs 3,049.70 so far during the day. The stock had hit a 52-week high of Rs 3,689 on 20 July 2016. The stock had hit a 52-week low of Rs 2,814.80 on 15 February 2016.

The large-cap company has equity capital of Rs 82.87 crore. Face value per share is Rs 5.

Dr Reddys Laboratories (DRLs) consolidated earnings before interest, taxation, depreciation and amortization (EBITDA) declined 13.07% to Rs 8793 crore in Q3 December 2016 over Q3 December 2015. EBITDA margin contracted to 23.7% in Q3 December 2016, from 25.5% in Q3 December 2015.

DRLs revenues from global generics business declined 9% to Rs 3060 crore in Q3 December 2016 over Q3 December 2015 due to lower contribution from North America and Venezuela. Revenues from Pharmaceuticals services and active ingredients (PSAI) business rose 6% to Rs 540 crore in Q3 December 2016 over Q3 December 2015.

Dr Reddys Laboratories is an integrated global pharmaceutical company. It offers a portfolio of products and services including active pharmaceutical ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.

Powered by Capital Market - Live News

Blue Coast Hotels gains after reporting strong Q3 earnings
Feb 06,2017

The result was announced after market hours on Friday, 3 February 2017.

Meanwhile, the S&P BSE Sensex was up 217.68 points, or 0.77%, to 28,458.20.

On the BSE, 779 shares were traded on the counter so far as against the average daily volumes of 52 shares in the past one quarter. The stock had hit a low of Rs 129.85 so far during the day.

The stock had hit a 52-week high of Rs 173 on 5 July 2016 and a 52-week low of Rs 56.05 on 19 February 2016.

The small-cap company has equity capital of Rs 12.75 crore. Face value per share is Rs 10.

Blue Coast Hotels is engaged in hotel business. The company owns park Hyatt Goa Resort & Spa. Park Hyatt Goa Resort & Spa is a beach resort located at Arossim beach, Goa.

Powered by Capital Market - Live News

ACC shrugs off weak Q4 result
Feb 06,2017

The result was announced after market hours on Friday, 3 February 2017.

Meanwhile, the BSE Sensex was up 225.34 points, or 0.8%, to 28,465.86

On BSE, so far 52,000 shares were traded in the counter, compared with average daily volume of 1.51 lakh shares in the past one quarter. The stock hit a high of Rs 1,500 and a low of Rs 1,402 so far during the day. The stock hit a 52-week high of Rs 1,738 on 8 August 2016. The stock hit a 52-week low of Rs 1,173.25 on 29 February 2016.

The large-cap company has equity capital of Rs 187.79 crore. Face value per share is Rs 10.

ACCs consolidated operating earnings before interest, taxes, depreciation and amortization (EBITDA) declined 8.57% to Rs 256 crore in Q4 December 2016 over Q4 December 2015. Cement sales volumes fell 9.17% to 5.45 million tonnes in Q4 December 2016 over Q4 December 2015.

In its outlook, ACC said that the slowdown witnessed after demonetization is easing and the company expects the economy to show solid growth in the months to come. Increased government spending on infrastructure development, housing, roads, railways, irrigation and other schemes as announced in the Union Budget 2017-18 are expected to further reinvigorate the construction sector soon and boost demand for cement and concrete during the year, ACC said.

Neeraj Akhoury, who takes over as Managing Director & CEO of ACC said that the highlight of the year was strong cost saving measures, especially on fuel flexibility and raw materials. Focusing on high quality, high performance product portfolio played an important role in the overall performance for the year. The company is encouraged by the Governments plans to invest in infrastructure, Neeraj Akhoury said.

ACC is a manufacturer of cement and concrete and is a member of LafargeHolcim group. The company has a countrywide network of modern cement and concrete plants, sales offices, dealers and retailers.

Powered by Capital Market - Live News

Gravita India hits 52 week high after turnaround Q3 results
Feb 06,2017

The result was announced after market hours on Friday, 3 February 2017.

Meanwhile, the S&P BSE Sensex was up 184.97 points, or 0.65%, to 28,425.49.

On the BSE, 63,000 shares were traded on the counter so far as against the average daily volumes of 81,246 shares in the past one quarter. The stock had hit a high of Rs 49 so far during the day, which is also its 52-week high. The stock hit a low of Rs 45.55 so far during the day.

The stock had hit a 52-week low of Rs 16 on 24 June 2016.

The small-cap company has equity capital of Rs 13.69 crore. Face value per share is Rs 2.

Gravita Indias consolidated total revenue spurted 98.69% to Rs 166.68 crore in Q3 December 2016 over Q3 December 2015.

The companys earnings before interest, tax, depreciation and amortization (EBITDA) of Rs 14.25 crore in Q3 December 2016, compared with net loss of Rs 1.05 crore in Q3 December 2015.

Gravita India is engaged in the business of manufacturing of lead metal by recycling & smelting process.

Powered by Capital Market - Live News

Grasim Industries gains as board approves hike in investment limits by FPIs
Feb 06,2017

The announcement was made after market hours on Friday, 3 February 2017.

Meanwhile, the BSE Sensex was up 226.27 points, or 0.8%, to 28,466.79

On the BSE, 8,368 shares were traded in the counter so far, compared with average daily volume of 54,097 shares in the past one quarter. The stock had hit a high of Rs 965 and a low of Rs 952.35 so far during the day. The stock had hit a record high of Rs 1,069.70 on 5 August 2016. The stock had hit a 52-week low of Rs 648.41 on 26 February 2016.

The large-cap company has equity capital of Rs 93.36 crore. Face value per share is Rs 2.

Grasim Industries said that directors vide a circular resolution passed on 3 February 2017, approved the proposal to increase the limits for investment in the equity share capital of the company by registered foreign portfolio investors (RFPIs) to 49% from 30% of the companys total paid-up equity share capital of the company.

Grasim Industries consolidated net profit rose 13.7% to Rs 728.19 crore on 1.47% rise in total income to Rs 8813.24 crore in Q3 December 2016 over Q3 December 2015.

Grasim Industries two main businesses are viscose staple fibre (VSF) and cement.

Powered by Capital Market - Live News

Lupin gains after US drug regulator nod for generic drug
Feb 06,2017

The announcement was made after market hours on Friday, 3 February 2017.

Meanwhile, the S&P BSE Sensex was up 159.34 points or 0.56% at 28,399.86

On the BSE, 1,663 shares were traded on the counter so far as against the average daily volumes of 78,851 shares in the past one quarter. The stock had hit a high of Rs 1,511 and a low of Rs 1,502.50 so far during the day. The stock had hit a 52-week high of Rs 1,911.55 on 9 February 2016 and a 52-week low of Rs 1,294.05 on 29 March 2016.

The large-cap company has equity capital of Rs 90.30 crore. Face value per share is Rs 2.

Lupin announced that it has received final approval for its Triamcinolone Acetonide Cream USP, 0.025%, 0.1% and 0.5% from the United States Food and Drug Administration (FDA) to market a generic equivalent of Mylan Pharmaceuticals Inc.s Triamcinolone Acetonide Cream, 0.025% and 0.1%. Lupin shall commence promoting the product shortly.

Lupins Triamcinolone Acetonide Cream USP, 0.025%, 0.1% and 0.5% is an AT rated generic equivalent of Mylan Pharmaceuticals, Inc.s (formerly held by Delcor Asset Corporation) Triamcinolone Acetonide Cream, 0.025% and 0.1%. Triamcinolone Acetonide Cream USP, 0.025%, 0.1% and 0.5% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.

Triamcinolone Acetonide Cream USP, 0.025%, 0.1% and 0.5% had US sales of $55.7 million as per IMS MAT September 2016.

Lupins consolidated net profit rose 57.8% to Rs 662.19 crore on 31.9% rise in net sales to Rs 4211.18 crore in Q2 September 2016 over Q2 September 2015.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally. The company is a significant player in the cardiovascular, diabetology, asthma, pediatric, CNS, GI, anti-infective and NSAID space and holds global leadership position in the anti-TB segment.

Powered by Capital Market - Live News